This article describes a randomized trial investigating the effectiveness of targeted patient-centred pharmacist-physician team medication therapy management (MTM) on clinical dementia rating (CDR). The findings show promise to optimizing outcomes for medication use in older adults. 10 pages. Last reviewed September, 2018.
This clinical practice guideline is intended to help clinicians make decisions about when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs). This guideline applies to patients who are using BZRAs to treat primary insomnia or comorbid insomnia where the potential comorbidities are effectively managed. 13 pages. Last reviewed June 2018.
On May 25, 2018 Dr. Leah Nemiroff gave this presentation which uses a case study approach to introduce polypharmacy, define deprescribing, review screening tools, guidelines, data investigating medication use at the end of life and barriers to deprescribing. 49 slides. Last reviewed May 2018.
This article discusses a number of considerations for managing multimorbidity in people with chronic respiratory conditions including: the use of care planning, addressing polypharmacy, comorbid mental health conditions, and drug reactions, factors such as gender and socio-economic status, health promotion /opportunistic screening and shared decision making.
Wed. Jan. 24, 2018 from 12-1pm EST. Join Todd Campbell Lee and Emily McDonald from McGill University Health Centre as they talk about their intervention to automate the process of deprescribing. Register here.
This webpage discusses the demographics and prevalence of substance abuse among older adults, physical and psychological aspects of substance abuse and misuse, barriers to identification and treatment and needed actions.
The Rheumatoid Arthritis Support Network website is a resource page where people can find information on living with RA. Symptoms of rheumatoid arthritis can make it difficult to live a full, healthy life. Fortunately, there are many ways to manage these symptoms — from medications to lifestyle changes.
The aim of this paper was to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review, and expert panel and three survey rounds. Last reviewed January 2017.